What Researchers Did
Researchers investigated how increasing pressure in a hyperbaric chamber affected the release of a specific hormone related to urination in seven healthy volunteers, and if oxygen therapy could reverse these changes.
What They Found
They found that at 2 atmospheres absolute (ATA), the circulating levels of the N-terminus of the ANF prohormone increased threefold, and at 3 ATA, they increased sixfold compared to sea level (1 ATA). When 100% oxygen was given at 3 and 2 ATA, these hormone levels immediately decreased to their normal pre-pressure levels and stayed there during decompression.
What This Means for Canadian Patients
This study provides insight into how the body responds to changes in pressure, specifically regarding increased urination. Understanding these physiological changes could be important for Canadian patients undergoing hyperbaric oxygen therapy or those involved in diving, as it helps explain why increased urination might occur during hyperbaric exposures.
Canadian Relevance
Although this was not a Canadian study, it covers physiological responses to pressure relevant to hyperbaric oxygenation and decompression. Decompression sickness is a Health Canada-recognized indication for hyperbaric oxygen therapy.
Study Limitations
A limitation of this study is its small sample size of seven healthy volunteers, meaning the findings may not apply to all individuals or those with underlying health conditions.